Real-life comparison between secukinumab and ixekizumab in the treatment of pustular and erythrodermic psoriasis

J Eur Acad Dermatol Venereol. 2022 Jul;36(7):e574-e576. doi: 10.1111/jdv.18069. Epub 2022 Mar 24.

Authors

G Avallone¹, C Cariti¹, P Dapavo¹, M Ortoncelli¹, L Conforto¹, L Mastorino¹, G Roccuzzo¹, F Cavallo¹, M Rubatto¹, P Quaglino¹, S Ribero¹

Affiliation

¹ Dermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.

PMID: 35279885
DOI: 10.1111/jdv.18069

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Humans
Psoriasis* / drug therapy
Severity of Illness Index
Treatment Outcome

Substances

Antibodies, Monoclonal, Humanized
ixekizumab
secukinumab